-
-
Call more information
660-596-2224 -
Author: Rebecca Pifer Healthcare Dive The Part B premium hike could have been worse, the Trump administration said. Still, it’s likely to pressure the pocketbooks of millions of seniors, and could drive more into Medicare Advantage plans. Dive Brief: Medicare beneficiaries will see their premiums increase 10% next year as the massive federal insurance program […]
Read MoreAuthors: Omoto M et al. Anesthesia & Analgesia 141(5):998–1006, November 2025.DOI: 10.1213/ANE.0000000000007409 SummaryThis nationwide retrospective study analyzed all unplanned ICU admissions occurring directly from the operating room after elective surgery using Japan’s ICU database (JIPAD) from 2015–2022. Among nearly 142,000 elective surgical patients, 2666 (1.9%) required an unexpected postoperative ICU transfer. These patients were very […]
Read MoreAuthor: Sophie Eydis Becker’s ASC Review Anesthesia groups are facing mounting pressure to demonstrate measurable value as reimbursement declines, staffing shortages intensify and hospitals reevaluate contract structures. Once viewed primarily as clinical support services, anesthesia practices are reshaping their models to show direct contributions to quality, efficiency and cost containment. Here are five key ways […]
Read MoreAuthor: Sophie Eydis Becker’s ASC Review As anesthesia groups prepare for 2026, pressures from reimbursement cuts, workforce shortages and rising operational costs are intensifying. Here are five data points fueling concern about the year ahead: 1. Anesthesia compensation is declining in real terms: CMS’ 2025 anesthesia conversion factor decreased by 2.20%, continuing a multiyear erosion of reimbursement that […]
Read MoreBecker’s Hospital Review Sufentanil injections: Pfizer, the sole supplier of the opioid agonist, has Sufentanil 50 micrograms per 1 milliliter vials on back order and expects a release date in November. The therapy is indicated as an analgesic in the maintenance of balanced general anesthesia and with bupivacaine.
Read More